Skin Disorders and Primary Tumor Location as Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with Cetuximab and Chemotherapy

BACKGROUND: Cetuximab-induced skin disorder is common in colorectal cancer (CRC), and is known to affect prolonged overall survival (OS). Patients with left-sided CRC survive longer than those with right-sided CRC, among those treated with combination cetuximab and chemotherapy. However, no study ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Shinya, Sagawa, Tamotsu, Fujikawa, Koshi, Tahatsu, Kanae, Fukai, Yuta, Hashishita, Hirokazu, Takahashi, Yasuo, Endo, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171408/
https://www.ncbi.nlm.nih.gov/pubmed/30141310
http://dx.doi.org/10.22034/APJCP.2018.19.8.2325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171408/
https://www.ncbi.nlm.nih.gov/pubmed/30141310
http://dx.doi.org/10.22034/APJCP.2018.19.8.2325

Ejemplares similares